SARS-CoV-2 vaccination
Showing 1 - 25 of >10,000
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in
Not yet recruiting
- Systemic Sclerosis
- SARS-CoV 2 Vaccination
- (no location specified)
Jul 24, 2023
SARS-CoV-2 Vaccination on Cancer Patients Infected With
Recruiting
- COVID-19 Infection
- COVID-19 Vaccine
- no intervention
-
Beijing, Beijing, ChinaSanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
Mar 7, 2023
Systemic Lupus Trial in Strasbourg (SRAS-CoV-2 vaccination immunological response)
Recruiting
- Systemic Lupus
- SRAS-CoV-2 vaccination immunological response
-
Strasbourg, Bas-Rhin, FranceUniversity Hospital of Hautepierre
Aug 17, 2022
SARS Cov 2 Vaccination in Juvenile Idiopathic Arthritis
Recruiting
- SARS Cov 2 Vaccination in Adolescents With Juvenile Idiopathic Arthritis
-
Nantes, Loire-Atlantique, FranceCHU de Nantes
Sep 16, 2022
COVID-19 Transmission and Morbidity in Malawi
Recruiting
- SARS CoV 2 Infection
- SARS CoV 2 Vaccination
-
Boston, Massachusetts
- +1 more
Aug 6, 2023
Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients
Completed
- SARS-CoV-2 Vaccination
- Liver Transplantation
- Immunoassay, by ECLIA, for the quantitative in vitro determination of antibodies (including IgG) to the SARS - CoV - 2 spike protein (S) anti-RBD (receptor-binding domain) in serum and plasma samples.
-
Roma, ItalyPoliclinico Tor Vergata
Aug 3, 2022
Vaccination Hesitancy Trial in Oklahoma City, Stillwater (Standard MI, Intensive MI, MOTIVACC)
Not yet recruiting
- Vaccination Hesitancy
- Standard MI
- +3 more
-
Oklahoma City, Oklahoma
- +1 more
Aug 2, 2023
Sars-cov-2 on Donor Oocyte Quality and Quantity,Multicenter
Completed
- Ovarian Reserve
- +2 more
- Sars Cov 2 infection
- Sars Cov 2 vaccination
-
Bogotá, ColombiaNovafem
Oct 3, 2022
SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- 0.9% sodium chloride solution
-
Islamabad, PakistanSindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023
CORONAVIRUS INFECTIONS Trial (anti-SARS-Cov-2 vaccination)
Not yet recruiting
- CORONAVIRUS INFECTIONS
- anti-SARS-Cov-2 vaccination
- (no location specified)
Dec 15, 2022
After SARS CoV2 Vaccination in Kidney Transplant Recipients
Recruiting
- Kidney Transplant Recipients
- Study of the synthesis of antibodies directed against SARS
-
Strasbourg, FranceCaillard Sophie
Aug 18, 2022
Epileptic Seizure in Epilepsy Patients After SARS-CoV-2
Completed
- Epileptic Seizures Related to Drugs
- +2 more
- inactive SARS-Cov-2 vaccine
-
Xi'an, Shaanxi, ChinaXijing Hospital
Apr 16, 2022
SARS-CoV-2 Trial in Beijing (Probiotics daily, Placebo daily)
Completed
- SARS-CoV-2
- Probiotics daily
- Placebo daily
-
Beijing, China
- +1 more
Jul 3, 2022
Saxon SARS-CoV-2 Infection and Vaccination Study in Dialysis
Recruiting
- SARS-CoV-2 Infection
- +3 more
-
Dresden, Saxony, GermanyUnivercity Hospital Carl Gustav Carus
Aug 2, 2022
Myocarditis and Cardiomyopathy Trial in Mannheim
Recruiting
- Myocarditis and Cardiomyopathy
-
Mannheim, Baden Württemberg, GermanyTheresienkrankenhaus
Mar 3, 2022
RECOVAC - Long Term Efficacy and Safety of COVID-19 Vaccination
Active, not recruiting
- Covid19
- +2 more
- mailer-based finger-prick
-
Groningen, NetherlandsUniversity Medical Center Groningen
Mar 14, 2022
Does Repeat Influenza Vaccination Constrain Influenza Immune
Recruiting
- Influenza, Human
- SARS-CoV-2 Infection
- Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
- SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
-
New Lambton Heights, New South Wales, Australia
- +5 more
Nov 7, 2022
SARS-CoV-2 Trial in Beijing (1 week (Week 1), 1 week of probiotics(Week 1), 1 week (Week 2))
Recruiting
- SARS-CoV-2
- 1 week placebo(Week 1)
- +5 more
-
Beijing, China
- +1 more
Jul 3, 2022
SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)
Not yet recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA Vaccine
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
Jul 7, 2023
Intention to Get SARS-CoV-2 Vaccination, Intention to Get SARS-CoV-2 Antibody Test Trial (Theory of planned behaviours (TPB)
Not yet recruiting
- Intention to Get SARS-CoV-2 Vaccination
- Intention to Get SARS-CoV-2 Antibody Test
- Theory of planned behaviours (TPB) based intervention
- (no location specified)
Mar 11, 2022
COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)
Not yet recruiting
- COVID-19 Vaccine
- COVID-19
- 50 μg Baiya SARS-CoV-2 Vax 2
- Placebo
-
Bangkok, ThailandQueen Saovabha Memorial Institute
May 23, 2023
Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in
Active, not recruiting
- SARS-CoV-2 RNA Vaccines
- HIV Infection
- SARS-CoV-2 Vaccine
-
Sevilla, SpainVirgen del Rocio University Hospital
Dec 1, 2022
SARS-CoV-2 Vaccine Tolerability and Clinical Outcome Among
Completed
- SARS-CoV2 Infection
- +3 more
- IM injection of vaccination (mRNA vaccination)
- IM injection of vaccination (vector based vaccination)
-
Hildesheim, Niedersachsen, GermanyHelios Hospital Hildesheim
Dec 29, 2022
COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)
Recruiting
- COVID-19
- the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
-
Guangzhou, Guangzhou, ChinaThe Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023
Non-hodgkin Lymphoma,B Cell, Vaccination Failure Trial (Immunological analyses)
Not yet recruiting
- Non-hodgkin Lymphoma,B Cell
- Vaccination Failure
- Immunological analyses
- (no location specified)
Sep 13, 2021